<DOC>
	<DOCNO>NCT01863173</DOCNO>
	<brief_summary>effect B blocker first evaluate patient cardiomyopathy induce ischemia idiopathic common cause cardiomyopathy . Effect BB Thalassemia cardiomyopathy evaluate study</brief_summary>
	<brief_title>Effect Metoprolol Thalassemia Cardiomyopathy</brief_title>
	<detailed_description>In clinical trial , 45 patient thalassemia cardiomyopathy randomize receive either metoprolol ( n = 26 ) placebo ( n = 19 ) . Echocardiography 6 minute walk test perform baseline repeat 6 month value compare .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>document LVEF &lt; 50 % echocardiography B thalassemia No decompensated heart failure least 4 week ( hospitalization CHF , worsen low extremity edema , worsen dyspnea exertion , , orthopnea ) evidence acute myocarditis hemoglobin level 7 gr‚ÅÑdL . pulse rate 60/min systolic blood pressure le 90 mmHg evidence peripheral vascular disease major depression , history asthma , PR interval 240 msec , second third degree AV block major medical disease include diabetes mellitus require insulin injection , hypothyroidism , hypoparathyroidism , chronic renal failure ( glomerular filtration rate 30 ml/min ) , hepatic cirrhosis , hepatitisB hepatitisC , positive test human immunodeficiency virus , hemoglobinopathy</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Thalassemia cardiomyopathy</keyword>
	<keyword>metoprolol succinate</keyword>
	<keyword>echocardiography</keyword>
	<keyword>six minute walk test</keyword>
</DOC>